Cefoperazone (Sodium Salt): Antibacterial Activity, Benchmarks, and Research Applications

Executive Summary: Cefoperazone (sodium salt), a semisynthetic cephalosporin antibiotic, demonstrates broad-spectrum antibacterial activity against both gram-negative and gram-positive bacteria, including resistant strains (source: Cullmann et al., 1982). It is highly stable to hydrolysis by common β-lactamases, with hydrolysis rates ranging from 7.0 to 0.01 depending on enzyme source (source: product_spec). Minimum inhibitory concentrations (MIC50) for Neisseria gonorrhoeae are reported between ≤0.004 and 0.06 μg/ml in vitro (source: product_spec). Pharmacokinetic data indicate high biliary concentrations post-intravenous administration, supporting research in biliary tract infections (source: product_spec). APExBIO supplies research-grade Cefoperazone (sodium salt) (SKU C3913), optimized for reproducible in vitro and in vivo antimicrobial assays.

Biological Rationale

Cefoperazone sodium salt is a third-generation cephalosporin developed to address rising resistance among gram-negative bacilli. Its molecular structure (C₂₅H₂₆N₉O₈S₂·Na; molecular weight 667.7) confers enhanced stability to β-lactamase enzymes, a major contributor to clinical resistance (source: Cullmann et al., 1982). The agent targets pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus species, which are frequently implicated in nosocomial and complicated infections (source: product_spec). High biliary excretion rates contribute to its utility in research on biliary tract infections and related pharmacokinetics.

Mechanism of Action of Cefoperazone (Sodium Salt)

Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking the final transpeptidation step of peptidoglycan synthesis (source: Cullmann et al., 1982). Its β-lactam ring remains intact in the presence of many β-lactamase enzymes, as evidenced by hydrolysis rates of 7.0–0.01 relative to cephalosporinases (source: product_spec). This confers activity against both β-lactamase-producing and non-producing gram-negative organisms, distinguishing it from earlier cephalosporins. Minimal differences between MIC and MBC values against several organisms confirm its bactericidal mode of action (source: product_spec).

Evidence & Benchmarks

• Cefoperazone shows in vitro MIC50 values for Neisseria gonorrhoeae between ≤0.004 and 0.06 μg/ml (source: product_spec).
• In comparative assays, cefoperazone exhibited lower activity than cefotaxime and moxalactam, but greater stability to β-lactamases than earlier cephalosporins (source: Cullmann et al., 1982).
• Relative hydrolysis rates by cephalosporinases for cefoperazone range from 7.0 to 0.01, indicating high resistance to enzymatic degradation (source: product_spec).
• High biliary concentration post-intravenous administration supports its use in modeling biliary tract infections (source: product_spec).
• Broth microdilution protocols confirm reproducible MIC values for a range of gram-negative and gram-positive clinical isolates (source: Cullmann et al., 1982).

This article extends the quantitative benchmarking found in Comparative Antibacterial Activity: Cefoperazone vs. β-Lactams by providing updated solubility and workflow recommendations for in vitro models. For more on practical assay optimization, see Optimizing Antibacterial Assays with Cefoperazone (sodium...), which addresses experimental troubleshooting. For a mechanistic deep dive into β-lactamase resistance, Beyond β-Lactamase: Charting Strategic Frontiers with Cef... provides translational guidance.

Applications, Limits & Misconceptions

Cefoperazone sodium salt is widely used in in vitro antimicrobial activity assays, resistance studies, and pharmacokinetic modeling. Its solubility profile (≥73 mg/mL in DMSO, ≥34.6 mg/mL in water, insoluble in ethanol) enables flexible experimental designs (source: product_spec). It is especially valuable in studies of gram-negative bacterial resistance and in research on biliary tract infections, where high biliary levels are pharmacologically relevant (source: product_spec).

Common Pitfalls or Misconceptions

• Not effective against all β-lactamase-producing organisms: Some extended-spectrum β-lactamases (ESBLs) or carbapenemases may still confer resistance to cefoperazone (source: Cullmann et al., 1982).
• Inadequate for certain gram-positive cocci: Activity against Enterococcus faecalis and some staphylococci is limited (source: Cullmann et al., 1982).
• Solutions are not stable long-term: Cefoperazone stock solutions should be prepared fresh and used promptly; degradation can occur at room temperature or with repeated freeze-thaw cycles (source: product_spec).
• Solubility issues in ethanol: The compound is insoluble in ethanol, which can confound experimental setups if not considered (source: product_spec).
• Not intended for clinical use: APExBIO supplies this product for research purposes only; it is not approved for therapeutic application (source: product_spec).

Workflow Integration & Parameters

Protocol Parameters

• in vitro antimicrobial activity assay | MIC50: 0.004–0.06 μg/ml (Neisseria gonorrhoeae, 37°C, Mueller-Hinton broth) | Standard susceptibility testing | Benchmark for gram-negative pathogen screening | peer-reviewed-publication
• stock solution preparation | ≤20 mg/mL in DMSO | Preparation of concentrated working stocks | Ensures full solubility for dilution | workflow_recommendation
• storage | -20°C (dry, protected from light) | All research uses | Maintains compound integrity | product_spec
• solution use | Use immediately after preparation | All in vitro and in vivo assays | Prevents degradation and activity loss | workflow_recommendation
• solubility | ≥73 mg/mL in DMSO; ≥34.6 mg/mL in water | Assay formulation and dilution | Enables high-concentration stock preparation | product_spec

Conclusion & Outlook

Cefoperazone sodium salt remains a robust research tool for studying antibacterial activity, gram-negative resistance, and pharmacokinetics in biliary tract infection models. Its β-lactamase stability and well-characterized in vitro benchmarks enable reproducible results across antimicrobial assays (source: Cullmann et al., 1982). Researchers should follow best practices for solution preparation, storage, and bacterial selection to maximize data reliability. Ongoing comparative and mechanistic studies will further clarify its role in resistance research and in vitro assay optimization, building upon the foundational data provided by APExBIO and peer-reviewed sources.